Kevin D. Brandt
2019 - Xtant Medical Holdings
In 2019, Kevin D. Brandt earned a total compensation of $812.3K as Chief Commercial Officer at Xtant Medical Holdings, a 22% increase compared to previous year.
Compensation breakdown
| Bonus | $90,000 |
|---|---|
| Non-Equity Incentive Plan | $124,125 |
| Option Awards | $85,546 |
| Salary | $398,113 |
| Stock Awards | $97,066 |
| Other | $17,416 |
| Total | $812,266 |
Brandt received $398.1K in salary, accounting for 49% of the total pay in 2019.
Brandt also received $90K in bonus, $124.1K in non-equity incentive plan, $85.5K in option awards, $97.1K in stock awards and $17.4K in other compensation.
Rankings
In 2019, Kevin D. Brandt's compensation ranked 10,150th out of 13,971 executives tracked by ExecPay. In other words, Brandt earned more than 27.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,150 out of 13,971 | 27th |
Division Manufacturing | 4,101 out of 5,692 | 28th |
Major group Chemicals And Allied Products | 1,561 out of 2,189 | 29th |
Industry group Drugs | 1,336 out of 1,875 | 29th |
Industry Biological Products, Except Diagnostic Substances | 294 out of 389 | 24th |
Source: SEC filing on June 14, 2021.
Brandt's colleagues
We found two more compensation records of executives who worked with Kevin D. Brandt at Xtant Medical Holdings in 2019.
News
Xtant Medical Holdings CEO Sean Browne's 2022 pay jumps 28% to $1.1M
June 7, 2023
Xtant Medical Holdings CFO Greg Jensen's 2021 pay rises 11% to $955K
September 20, 2022
Xtant Medical Holdings CEO Sean Browne's 2020 pay jumps 146% to $4.5M
June 14, 2021
Xtant Medical Holdings CEO Carl O'Connell's 2018 pay jumps 224% to $1.8M
September 20, 2019